In presence of AKI, hospitalization stay, estimated in days, was significantly lower (p = 0.037) in Group A patients (receiving early treatment based on NGAL) than Group B patients (evaluated only with creatinine), as reported in Figure 3. This evidence concerns the gene LCN2 and acute kidney injury.